'HealthMammo' solution aims to support radiologists in their tumor diagnoses by identifying and prioritizing suspicious mammograms

FDA says the benefits of the antimalarial drug, which has been championed by Trump to treat COVID-19, 'do not outweigh the known and potential risks'

FDA last week gave emergency approval to medicine produced by Gilead Sciences; it is believed to shorten illness time in some, but effect on mortality rates still unclear

Defense Department working on new blood-based screening that identifies body's immune response, may find illness 4 days earlier than current swab tests

In preliminary US trial Gilead Science’s remdesivir shortens recovery time by 4 days; cleared for use for hospitalized patients with 'severe disease'

More than 70 companies have signed up to sell unvetted finger-prick antibody tests, which purport to identify those who previously had virus and developed some immunity to it

WHO officials says progress being made, but any immunizing solution will take time: 'There is only one thing more dangerous than a bad virus, and that’s a bad vaccine'

Hydroxychloroquine one of several drugs cited in recent days as being possibly effective against coronavirus; Israeli firm says it will provide as many as possible at no cost

Chloroquine already being prescribed as possible treatment for COVID-19, but official okay for use of anti-malarial drug still requires testing, FDA head says

FDA chief cites 'compassionate use' in decision to expand access to chloroquine; Trump says approval process was set to take months, will now be immediate